Your browser doesn't support javascript.
loading
Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial.
Tonga, Johanne B; Saltyte Benth, Jurate; Arnevik, Espen A; Werheid, Katja; Korsnes, Maria S; Ulstein, Ingun D.
Afiliação
  • Tonga JB; Department of Old Age Psychiatry, Oslo University Hospital, Gaustad, Postbox 4956, Nydalen, 0424Oslo, Norway.
  • Saltyte Benth J; Norwegian Health Association, Postbox 7139 Majorstuen, 0207Oslo, Norway.
  • Arnevik EA; Institute of Psychology, University of Oslo, Postbox 1094, Blindern, 0317Oslo, Norway.
  • Werheid K; Institute of Clinical Medicine, Campus Ahus, University of Oslo, P.O.Box 1171, 0318Blindern, Norway.
  • Korsnes MS; Health Services Research Unit, Akershus University Hospital, Postbox 1000, 1478Lørenskog, Norway.
  • Ulstein ID; Division of Mental Health and Addiction, Oslo University Hospital, Postbox 4956, Nydalen, 0424Oslo, Norway.
Int Psychogeriatr ; 33(3): 217-231, 2021 03.
Article em En | MEDLINE | ID: mdl-32131911
ABSTRACT

OBJECTIVE:

To evaluate the feasibility and effectiveness of the CORDIAL program, a psychosocial intervention consisting of cognitive behavioral therapy (CBT), cognitive rehabilitation, and reminiscence to manage depressive symptoms for people with mild cognitive impairment (MCI) or dementia.

DESIGN:

We conducted a randomized controlled trial, based on a two-group (intervention and control), pre-/post-intervention design.

SETTING:

Participants were recruited from five different old age psychiatry and memory clinics at outpatients' hospitals.

PARTICIPANTS:

Hundred and ninety-eight people with MCI or early-stage dementia were included. INTERVENTION The intervention group (n = 100) received 11 individual weekly sessions of the CORDIAL program. This intervention includes elements from CBT, cognitive rehabilitation, and reminiscence therapy. The control group (n = 98) received treatment-as-usual. MEASUREMENTS We assessed Montgomery-Åsberg Depression Rating Scale (MADRS) (main outcome), Neuropsychiatric Inventory Questionnaire, and Quality of Life in Alzheimer's disease (secondary outcomes) over the course of 4 months and at a 10-month follow-up visit.

RESULTS:

A linear mixed model demonstrated that the depressive symptoms assessed by MADRS were significantly more reduced in the intervention groups as compared to the control group (p < 0.001). The effect persisted for 6 months after the intervention. No significant differences between groups were found in neuropsychiatric symptoms or quality of life.

CONCLUSION:

Our multicomponent intervention, which comprised 11 individual sessions of CBT, cognitive rehabilitation, and reminiscence therapy, reduced depressive symptoms in people with MCI and dementia.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psicoterapia / Demência / Depressão / Disfunção Cognitiva Tipo de estudo: Clinical_trials / Diagnostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psicoterapia / Demência / Depressão / Disfunção Cognitiva Tipo de estudo: Clinical_trials / Diagnostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article